Board to consider second interim dividend for FY2026-27

Corporate Actions View source PDF Explain this filing

LALPATHLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.7%Reaction day

₹1890.00

prior close

₹1885.20

announcement price

After-mkt

timing

Nifty Smallcap 250marketpendingvs market: pending

Healthcare Service Provider peers, median of 27sector-0.1%+1.7% vs sector

On the reaction day the stock moved 1.7 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.1

15m

+0.1

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.7pendingpending-0.1+1.7

Next day

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board will meet on November 4, 2026 to review unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026, and consider a second interim dividend, if any, for FY2026-27. No amount has been announced.

Likely market impact

A possible dividend may support investor sentiment, but the amount and approval are not yet known, so its stock-price impact cannot be assessed.